OM1, Inc.

🤔 What’s Missing in your #Dermatology Research? Traditional data often falls short of capturing the complexities of #patientjourneys and treatment outcomes. That’s where the OM1 real-world dermatology data network steps in. In our ebook, learn how you can: ✅ Access rich, longitudinal data to understand patient journeys and treatment effectiveness ✅ Gain insights into unmet needs and therapeutic impacts ✅ Use AI-powered analytics to improve patient outcomes 📖 Read the ebook: https://okt.to/KQCZci #Derm #Pharma #LifeScience #MedicalAffairs #HEOR

Traditional #clinicalresearch methods are bogged down by inefficiencies, rigid designs, and limited diversity—leading to delays, higher costs, and incomplete insights. At #SCOPE2025, Catherine Richards, PhD MPH will share how #AI-powered, tech-enabled solutions are removing these barriers for prospective studies and registries, leading to: ✅ Flexible, adaptive approaches ✅ Reduced costs and faster up timelines ✅ More diverse and comprehensive #realworlddata for unmatched insights 📍 Learn more about OM1 at SCOPE: https://okt.to/RDQgY6 #RWD #HealthcareInnovation #HEOR #Pharma #LifeScience

The Agency for Healthcare Research and Quality (AHRQ) Registries for Evaluating Patient Outcomes: A User’s Guide serves as a reference for best practices to guide design, operation, analysis, and evaluation of #patientregistries. Rich Gliklich, CEO of OM1, has been a principal investigator and senior editor of the handbook, now in it's 4th edition, since it's inception. As a pioneer in #realworlddata and evidence generation, Dr. Gliklich’s expertise has shaped the way registries are used to improve #healthcare decisions and outcomes. 📖 Explore the guide and learn more: https://okt.to/YznrNR #HealthcareInnovation #RealWorldEvidence #RWD #ClinicalResearch #PatientOutcomes

💡 Does your #dermatology research have gaps from incomplete data? From #clinicaldevelopment to the clinic, OM1’s Dermatology Real-World Data Network provides the right insights, giving you a comprehensive view of the #patientjourney. 📍 Explore the possibilities:https://okt.to/uhTyvQ #RWD #RealWorldEvidence #HealthcareInnovation #Pharma #LifeScience

🌟#ICYMI, last week Nalu Medical, Inc. published findings from a study on healthcare resource utilization (HCRU) in #painmanagement with insights from the OM1 Real-World Data Cloud. 💰Research found Nalu PNS therapy in #chronicpain patients is associated with lower HCRU and a significant reduction in associated costs, including a 61% overall reduction in outpatient costs. 📍Read the full publication: https://okt.to/Wlubzg Taylor & Francis Group #HealthcareOutcomes #RealWorldEvidence #RealWorldData #Pharma #LifeScience

🔍 What’s stopping you from building a better #RWD network? Imagine having the power to accelerate timelines, enrich data quality, and tackle your toughest research challenges. Aspen isn’t just a network—it’s the key to unlocking smarter, faster, and more impactful evidence generation. 📍 Explore the possibilities: https://okt.to/xfhKcN #realworldevidence #healthcareinnovation #pharma #lifescience #clinicalresearch #HEOR

🎉 We’re thrilled to see Nalu Medical, Inc.’s groundbreaking findings in their latest publication, showcasing the use of Nalu PNS therapy in #chronicpain patients is associated with lower #healthcareresourceutilization and a significant reduction in associated costs. OM1 is proud to have supported this effort by providing robust, #realworlddata that enabled deeper insights that helped support key findings. 📍Read the full press release: https://okt.to/6YtbCM Taylor & Francis Group #HCRU #peripheralnervestimulation #realworldevidence #RWD #healthcareinnovation #precisionmedicine

⏰ Last Chance to Register! Tomorrow’s webinar will be packed with expert insights on #personalizedmedicine, #realworldevidence, and #AI for #MCED studies. Hear from our industry leading speakers: 🗣️ Eric Schrock 🗣️ Rich Gliklich 🗣️ Vijay Parthasarathy, PhD, MBA, Exact Sciences Secure your spot now and be part of the conversation shaping the future of #healthcare! 📍Register here 👉 https://okt.to/hOAmEx #MedicalAffairs #HEOR #RWE #HealthcareInnovation

💡 What’s holding you back from smarter, faster, and more impactful research? Traditional approaches to building #realworlddata networks are slow, rigid, and costly. Enter Aspen, OM1’s revolutionary platform that puts the power of on-demand #RWD networks in your hands. Lead with smarter data solutions that help you: ✅ Build custom, flexible networks tailored to your exact needs ✅ Leverage #AI to extract deeper insights and accelerate timelines ✅ Transform the way you approach evidence generation 📖 It’s time to rethink what’s possible. Read the Aspen eBook and take the leap forward: https://okt.to/Igh1SA #healthcarennovation #pharma #lifescience

🌟 2024 was a year of progress, insights, and big leaps forward. As we look back, the lessons learned can help us chart a clearer path for the future. This ebook captures top insights from our #AI-powered #realworlddata that shaped the #healthcare and #lifesciences landscape. 📚 Read it here 👉 https://okt.to/CtFflQ #DigitalHealth #DataDrivenInnovation